FDA Announces New Tool for Clinical Laboratories to Identify Validated Supply Alternatives for SARS-CoV-2 Testing
As of June 12, 2020, the FDA had authorized 135 COVID-19 tests under emergency use authorization (EUA), which include 114 molecular tests, 20 antibody tests, and 1 antigen test. The FDA has also released a new interactive tool designed to assist in identifying COVID-19 testing supply deficiencies and alternatives.
Clinical Laboratories Face Reimbursement Uncertainties Over SARS-CoV-2 Testing for Asymptomatic Individuals
In an exclusive interview, Danielle Sloane of Bass, Berry and Sims, discusses potentially tricky reimbursement for SARS-CoV-2 asymptomatic testing.